| Primary |
| Drug Use For Unknown Indication |
36.7% |
| Hiv Infection |
36.3% |
| Product Used For Unknown Indication |
6.8% |
| Antiretroviral Therapy |
6.1% |
| Hepatitis C |
1.7% |
| Systemic Antiviral Treatment |
1.7% |
| Depression |
1.5% |
| Acquired Immunodeficiency Syndrome |
1.1% |
| Hypertension |
1.1% |
| Opportunistic Infection Prophylaxis |
1.1% |
| Castleman's Disease |
0.9% |
| Cytomegalovirus Infection |
0.9% |
| Disseminated Tuberculosis |
0.7% |
| Viral Infection |
0.7% |
| Coronary Artery Disease |
0.6% |
| Prophylaxis |
0.6% |
| Sciatica |
0.6% |
| Antiviral Prophylaxis |
0.4% |
| Fibromyalgia |
0.4% |
| Gout |
0.4% |
|
| Death |
15.4% |
| Injection Site Reaction |
14.9% |
| Weight Decreased |
8.0% |
| Pyrexia |
6.3% |
| Disease Progression |
5.7% |
| Umbilical Cord Abnormality |
5.7% |
| Pneumonia |
5.1% |
| Rash |
4.0% |
| Lipodystrophy Acquired |
3.4% |
| Lymphadenopathy |
3.4% |
| Viral Load Increased |
3.4% |
| Vomiting |
3.4% |
| Drug Resistance |
2.9% |
| Pancreatitis |
2.9% |
| Paraesthesia |
2.9% |
| Renal Failure Acute |
2.9% |
| Weight Increased |
2.9% |
| Drug Administration Error |
2.3% |
| Lymphoma |
2.3% |
| No Adverse Effect |
2.3% |
|
| Secondary |
| Hiv Infection |
54.1% |
| Drug Use For Unknown Indication |
9.1% |
| Product Used For Unknown Indication |
5.0% |
| Retroviral Infection |
4.5% |
| Tuberculosis |
3.7% |
| Mycobacterium Avium Complex Infection |
3.2% |
| Systemic Antiviral Treatment |
2.6% |
| Prophylaxis |
2.1% |
| Drug Exposure During Pregnancy |
1.9% |
| Disseminated Tuberculosis |
1.8% |
| Antifungal Prophylaxis |
1.6% |
| Anaemia |
1.4% |
| Depression |
1.4% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Back Pain |
1.3% |
| Foetal Exposure During Pregnancy |
1.1% |
| Hiv Test Positive |
1.0% |
| Fungal Infection |
0.9% |
| Immune Reconstitution Syndrome |
0.9% |
| Cytomegalovirus Infection |
0.9% |
|
| Umbilical Cord Abnormality |
10.9% |
| Lymphadenopathy |
10.2% |
| Weight Decreased |
10.2% |
| Subdural Haematoma |
8.2% |
| Pyrexia |
6.8% |
| Pancreatitis |
5.4% |
| Stevens-johnson Syndrome |
5.4% |
| Pancytopenia |
4.1% |
| Plagiocephaly |
4.1% |
| Progressive External Ophthalmoplegia |
4.1% |
| Diaphragmatic Hernia |
3.4% |
| Immune Reconstitution Syndrome |
3.4% |
| Impaired Gastric Emptying |
3.4% |
| Rhabdomyolysis |
3.4% |
| Urticaria |
3.4% |
| Death |
2.7% |
| Febrile Neutropenia |
2.7% |
| Oedema Peripheral |
2.7% |
| Premature Baby |
2.7% |
| Rash Morbilliform |
2.7% |
|
| Concomitant |
| Hiv Infection |
61.6% |
| Drug Use For Unknown Indication |
16.8% |
| Prophylaxis |
2.7% |
| Acquired Immunodeficiency Syndrome |
2.6% |
| Diarrhoea |
2.0% |
| Mycobacterium Avium Complex Infection |
1.8% |
| Depression |
1.4% |
| Antifungal Prophylaxis |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Hypertension |
1.1% |
| Antiviral Prophylaxis |
0.9% |
| Insomnia |
0.9% |
| Pneumocystis Jiroveci Pneumonia |
0.8% |
| Antibiotic Prophylaxis |
0.8% |
| Hiv Test Positive |
0.8% |
| Antiretroviral Therapy |
0.7% |
| Candidiasis |
0.7% |
| Anxiety |
0.6% |
| Convulsion |
0.6% |
| Pain |
0.6% |
|
| Vomiting |
9.3% |
| Thrombocytopenia |
8.8% |
| Mental Status Changes |
8.4% |
| Renal Failure |
7.9% |
| Pyrexia |
7.0% |
| Weight Decreased |
6.5% |
| Renal Failure Acute |
6.0% |
| Haemorrhage Intracranial |
5.1% |
| Transaminases Increased |
4.2% |
| Varices Oesophageal |
4.2% |
| Liver Function Test Abnormal |
3.7% |
| Rash Maculo-papular |
3.7% |
| Squamous Cell Carcinoma |
3.7% |
| Hepatitis |
3.3% |
| Immune Reconstitution Syndrome |
3.3% |
| Meningitis Cryptococcal |
3.3% |
| Subdural Haematoma |
3.3% |
| Hypertension |
2.8% |
| Hypothermia |
2.8% |
| Syncope |
2.8% |
|
